Scribnil 50 Capsule
Marketer
Roulex Laboratories Pvt Ltd
Salt Composition
Pregabalin (50mg)
Overview Scribnil 50 Capsule
Neuracalm 50mg capsules alleviate nerve pain stemming from conditions like diabetes, shingles, spinal cord injury, or similar ailments. This medication also addresses widespread muscle pain and stiffness associated with fibromyalgia. Classified as an anticonvulsant, Neuracalm 50mg may be part of a treatment plan for specific seizure types. It might also be prescribed for anxiety symptoms when other treatments prove ineffective. Ingestion with or without food is acceptable, but consistent daily timing maximizes efficacy. Dosage and treatment length depend on individual response and condition; your physician will likely initiate a low dose with gradual increases. Full therapeutic effect may take several weeks. Adhere strictly to your doctor's instructions, maintaining regular intake until cessation is advised. Missed doses risk condition exacerbation. Side effects, usually mild and self-limiting, may include drowsiness, dizziness, dry mouth, blurred vision, weight gain, generalized edema, and concentration difficulties. Most require no medical intervention. Discuss any concerns with your doctor, exploring preventative or management strategies. Inform your physician of pregnancy, breastfeeding, or pregnancy plans prior to commencing treatment. Driving requires caution due to potential drowsiness, dizziness, and visual blurring. Concurrent alcohol consumption should be avoided to mitigate excessive sleepiness and dizziness.
Uses of Scribnil 50 Capsule
Managing neuropathic pain, fibromyalgia, and epilepsy/seizures.
Major Benefits of Scribnil 50 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Scribnil 50 Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.
Common Side effects of Scribnil 50 Capsule:
- Sleepiness
- Weight gain
- Dryness in mouth
- Blurred vision
- Dizziness
- Peripheral edema
How to use Scribnil 50 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Scribnil 50 Capsules. These capsules can be taken with or without food, though consistent timing is recommended.
How Scribnil 50 Capsule works:
Epileptic seizures are managed with Scribnil 50 Capsules, an anticonvulsant that suppresses excessive brain electrical discharges. Its mechanism of action involves dampening aberrant neuronal activity, thereby preventing seizure onset. This medication also provides relief from neuropathic pain by disrupting the transmission of pain impulses along damaged nerves to the brain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Scribnil 50 Capsules and alcohol may induce significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Scribnil 50 Capsules during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Scribnil 50 Capsule while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Scribnil 50 Capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Scribnil 50 Capsules. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Scribnil 50 Capsule poses no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Scribnil 50 Capsule :
Should you forget a Scribnil 50 Capsule dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Scribnil 50 Capsule
| Label | Value |
|---|---|
| Chemical Type | GABAergic Cyclic Analogs |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |



